ID-1101

• CAT Number: I006993
• CAS Number: 55399-93-4
• Molecular Formula: C6H13NO3
• Molecular Weight: 147.17
• Purity: ≥95%
• Synonyms: ID-1101; 4-OH-Ile; 4OHIle; ID 1101; 4 OH Ile; ID1101;(2S,3R,4S)-4-Hydroxyisoleucine
• Target: Disease Research Fields
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term or -20 °C for long term
• IUPAC Name: (2S,3R,4S)-2-amino-4-hydroxy-3-methylpentanoic acid
• InChI: InChI=1S/C6H13NO3/c1-3(4(2)8)5(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)/t3-,4-,5-/m0/s1
• InChIKey: OSCCDBFHNMXNME-YUPRTTJUSA-N
• SMILES: CC(C(C)O)C(C(=O)O)N

ID-1101 (CAT: I006993), also known as (2S,3R,4S)-4-Hydroxyisoleucine, is a natural compound derived from fenugreek with potent anti-diabetic properties. It functions by enhancing insulin secretion in a glucose-dependent manner, improving glucose metabolism, and reducing insulin resistance. This mechanism makes it highly effective in managing type II diabetes and mitigating diabetic nephropathy. As an orally active agent, ID-1101 offers a promising therapeutic option for metabolic disease research, supporting the development of novel treatments targeting glucose regulation and diabetic complications. Its dual action on insulin modulation and renal protection underscores its clinical relevance.